Film tip: Corona – in search of the truth – part 2

ServusTV: Measures to contain the coronavirus still determine our lives.

But which strategies make sense, and how do other countries act? Why do many US states have hardly any restrictions left? Is it because of the high vaccination rate? Or do they have better crisis management? How justified are concerns about vaccine side effects? And does it make sense to vaccinate children? Virologist Prof. Martin Haditsch meets leading scientists and critical doctors from around the world and asks concrete questions.

In spring 2021, newspapers wrote that a laboratory doctor had developed his own vaccine against Covid-19 and tested it on himself and his family. Only a few days later, numerous investigations were launched against him. What sounds like a dangerous experiment by an individual doctor is in fact the development of a medical professor who sold his last biotech company for more than one billion euros. Only a few media report on the success Prof. Stöcker achieved in a very short time. Stöcker claims he could supply all of Germany with vaccines within a few months.

Image source: servus.tv

Link to the programme of 14 July 2021 (97 min, German)

But the race for vaccines is being won by other companies, mostly working with mRNA technology.

Prof. Martin Haditsch visits this vaccine developer as well as Prof. Peter Kremsner, who, as head of the clinical trial, played a key role in developing the vaccine from the company CureVac – a novel mRNA-based vaccine. Even though CureVac ultimately missed its efficacy target, Peter Kremsner is considered a leading expert in vaccine development. What possibilities does the Tübingen scientist see in the new technology? And how does he assess the criticism from doctors who warn of dangers from this vaccine technology?

Prof. Martin Haditsch visits vaccine developers as well as critics of the comprehensive vaccination campaigns. Critics such as Michael Yeadon, former vice president and head of research at the pharmaceutical giant Pfizer, who has become a vehement opponent of this technology. He also meets Professor Jay Bhattacharya at Stanford, who argued early on for protecting vulnerable groups. And he talks to the German toxicologist and pharmacologist Stefan Hockertz.

Image and text source: ServusTV

Link to part 1 of the programme (German)